latest news.
Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable
The First Branded Fertility Drug to be Offered by Mark Cuban Cost Plus Drug Company
us.
Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are perpetually pursuing the highest quality standards, the most efficient supply chain and innovating every day in everything we do.

leadership.
Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.
products.
While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.

we care.
Cosette is committed to understanding patients’ unique health journeys so we can anticipate their needs and help achieve their goals.

newsroom.
Apurva Saraf, President and CEO of Cosette Pharmaceuticals, Honored with “CEO of the Year” Award by Avista Capital Partners
November 9, 2023
We’re thrilled to announce that Apurva Saraf, our esteemed President and CEO, has been recognized…
Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable
October 3, 2023
Cosette Pharma announced today that it has entered into an agreement with Mark Cuban Cost Plus Drug…
Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%
July 27, 2023
Cosette Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has…